AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for October 2026

BETHESDA, Md., Oct. 7, 2026 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for October 2026. The dividend is payable on November 10, 2026 to common stockholders of record as of October 30, 2026.

For further information or questions, please contact Investor Relations at (301) 968-9300 or [email protected].

ABOUT AGNC INVESTMENT CORP.

Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae. We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks.

AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $16 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles. AGNC is a member of many broad market indices, including the S&P MidCap 400, the S&P Composite 1500, the Russell 1000, the Russell 3000, and the Nasdaq Composite. To learn more about The Premier Agency Residential Mortgage REIT, please visit www.AGNC.com, follow us on LinkedIn and X, and sign up for Investor Alerts.

CONTACT:

Investor Relations - (301) 968-9300

SOURCE AGNC Investment Corp.

Share this article

In the news release, Cato Networks Appoints Former Palo Alto & Netskope Executive Chad Gardner as Chief Revenue Officer, issued 07-Oct-2026 by Cato Networks over PR Newswire, we are advised by the company that additional information has been added to clarify the scope of Chad's role in the first paragraph. An additional quote from Alon Alter, Cato's CBO has also been added after the third paragraph. The complete, corrected release follows:

Cato Networks Appoints Former Palo Alto & Netskope Executive Chad Gardner as Chief Revenue Officer

Gardner brings more than two decades of global sales leadership across cybersecurity, cloud, networking, and enterprise technology

TEL AVIV, Israel, Oct. 7, 2026 /PRNewswire/ -- Cato Networks, the converged network and security cloud for the AI era, today announced the appointment of Chad Gardner as chief revenue officer (CRO). Gardner will lead Cato's global sales organization and execution as enterprises modernize and converge their networking and security infrastructure, while securely adopting AI.

Gardner joins Cato from Blackfoot Communications, where he served as chief revenue officer, overseeing the company's wholesale, premier, and enterprise business units. He brings extensive experience building and leading high-performing sales organizations across enterprise infrastructure and cybersecurity. Previously, Gardner was vice president of sales for North America at SambaNova Systems and held several leadership roles at Palo Alto Networks, including vice president of global SASE sales and vice president of sales for West Majors. His experience also includes VP leadership positions at Netskope, as well as executive sales roles at Denali Advanced Integration, NetApp, and Cisco Systems.

"Chad has the experience, customer focus, and leadership ability to help Cato capitalize on the significant opportunity ahead," said Shlomo Kramer, co-founder and CEO of Cato Networks. "His experience leading global SASE sales gives him a clear understanding of why enterprises are moving to converged networking and security. He brings the sales leadership and customer focus we need to expand our business while staying focused on the customer experience that differentiates Cato."

"Chad is a proven sales leader who understands how to build high-performing teams, deepen customer relationships, and scale execution in fast-moving markets. His experience across SASE, cybersecurity, and enterprise technology makes him exceptionally well suited to lead Cato's sales organization," said Alon Alter, chief business officer, Cato Networks. "I'm excited to welcome him to the team as we help more organizations converge their network and security for today's AI era."

"I am excited to join Cato because it is uniquely positioned to define the future of networking and AI security. The company combines a compelling vision with its architecture to deliver meaningful outcomes for customers," said Gardner. "Cato's ability to simplify security while helping organizations adopt AI securely was a particularly important reason for me to join. I'm excited to partner with this team to scale the business, strengthen customer and partner relationships, and help organizations operate with the speed and confidence required in the AI era."

For more on Cato's leadership team, visit: https://www.catonetworks.com/company/

About Cato Networks

Cato Networks delivers the converged network and security cloud for the AI era. Cato unifies networking, security, and access to provide complete visibility across the enterprise, shared context across users, applications, data, and AI interactions, and unified control to act on that intelligence. Cato combines AI-powered security with autonomous protection to defend against evolving threats, secure AI adoption, and help organizations stay ahead of an increasingly AI-driven threat landscape. Trusted by thousands of organizations worldwide, Cato simplifies operations, strengthens resilience, and accelerates secure innovation.

Want to learn why thousands of organizations secure their future with Cato? Visit us at www.catonetworks.com

Media Contact

Cato Communications

[email protected]

SOURCE Cato Networks

Share this article

AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flex (NASDAQ: FLEX) will announce its second quarter fiscal year 2027 financial results before the market opens on Wednesday, October 28, 2026. The company will hold a conference call to discuss the results that day at 7:30 AM CT / 8:30 AM ET.

The live webcast presentation will be available on the Flex investor relations website at investors.flex.com. A replay of the webcast, along with supporting materials, will be available on the investor relations website following the conclusion of the event.

About Flex

Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps leading brands design, build, and manage products that improve the world. With a global footprint spanning 30 countries, Flex delivers advanced manufacturing and supply chain solutions, innovative products and technology, and lifecycle services that support customers from concept to scale. In the AI era, Flex is helping customers accelerate data center deployment by solving power, heat, and scale challenges through cutting-edge power and cooling technology and scalable IT infrastructure solutions.

Media, Investors, & Analysts

Michelle Simmons

Senior Vice President, Global Investor Relations and Public Relations

(669) 242-6332

[email protected] 

SOURCE Flex

Share this article

Gusto highlights new updates to Gusto Pro and the Gusto Partner Program; Gusto also launches new multi-client Model Context Protocol to bring Gusto's context directly into the AI tools accountants already work in

SAN FRANCISCO, Oct. 7, 2026 /PRNewswire/ -- Gusto, the leading partner for small businesses and their accountants, today announced some of its most extensive updates for accountants – a rebuilt Gusto Pro, a new multi-client Model Context Protocol (MCP), and an expanded Gusto Partner Program, designed to bring Gusto's business context directly into accountants' AI tools.

The announcements were made at Gusto Next, Gusto's event for its accounting partners, and are designed to help firms move from transactional tasks toward higher-value advisory services for their small business clients.

The announcement comes as small businesses launch at near historic highs, while needing guidance around compliance, multi-state hiring, benefits, and financial planning. At the same time, AI is reshaping the accounting profession, just as small business clients are asking for more support. A recent Gusto Insights report found that nearly half of small businesses want strategic financial advice from their accountant, not just tax preparation and bookkeeping.

Gusto Pro is Gusto's platform for accounting firms, helping them manage clients' payroll, benefits, and advisory services from a single dashboard. Today's update is its most significant since 2021. The redesigned platform now includes AI-assisted workflows, a multi-client assistant, and a simplified dashboard built to free up accountants from manual tasks, empowering them to do the advisory work only they can do.

The updated Gusto Pro is now available in early access to eligible Gusto partners, with general availability coming later this year. New features include:

- AI-assisted workflows that automate core payroll tasks end-to-end, like extracting hours from emails, surfacing changes since last payroll, and delivering critical reports — so firms spend less time on manual prep, while still retaining visibility and control. Once AI completes the prep, accountants review and give final approvals.

- Automated reporting, where Gusto learns which reports accountants pull after every payroll and automatically generates them. These reports land in one centralized place across all clients, so accountants don't need to find reports client-by-client

- New connectors to wherever accountants complete their work, like Gmail and Outlook for drafting hours, reimbursements, and deductions. This frees up accountants from chasing clients for vital information that then needs to be inputted manually into Gusto

- Pro Gus, our AI assistant, purpose-built to give accountants faster answers to client questions, plus multi-client visibility across their entire book of business

In addition to redesigning Gusto Pro, Gusto launched its multi-client Model Context Protocol (MCP), which brings Gusto's business context directly into the AI tools accountants already work in, across every client they manage.

Until now, working with AI across a client book has meant connecting to one client at a time and disconnecting and reconnecting to switch. With the multi-client MCP, accountants connect Gusto once, choose which clients to include, and every Gusto tool works across them from a single conversation.

Accountants can ask questions across their book of business, prep payroll changes like hours, earnings, time off, and payment methods, and generate the reports they run every cycle. They can also set up recurring routines that run in the background. Every change still comes back to the accountant to review and approve before anything is updated in Gusto, and only the clients they've chosen are ever connected.

Gusto's multi-client MCP is now available to all accountant firms, with more capabilities coming soon.

Finally, Gusto announced major upgrades to the Gusto Partner Program, a free, tiered program that rewards firms with revenue share and deeper strategic support as they grow their practice on Gusto. New features include:

- Marketing Development Funds and the Partner Marketing Hub — Marketing support designed to help firms grow their books. This includes Marketing Development Funds designed to help firms drive new client acquisition through email campaigns, webinars, events, or paid social promotion, as well as a Partner Marketing Hub providing AI agents, campaign building, and ready-to-launch marketing resources

- Partner Development Funds – Built to help firms grow stronger from the inside with the support of Firm Business Consultants. Funds can go toward launching and improving AI adoption and implementation, pricing and strategy for client advisory services, operational efficiency, and marketing matching firms with the right expertise for where they want to grow

- Firm Business Consultants – An exclusive, pre-vetted network of consultants with deep accounting industry experience providing specialized support across key growth areas

- AI agents for growth – First introduced in June 2026 and built exclusively for Gusto Pro firms. These include a website audit agent, advisory positioning agent, expansion pitch agent, and pricing and margin target agent — all designed to help firms win new clients and deepen advisory revenue

In mid-November 2026, the Gusto Partner Program will also expand revenue share beyond payroll to include 401(k) plans at partners' matching tier rate. New firms that join will also get a free firm 401(k) plan for owners and employees for one year.

Accountants can learn more about today's announcements at gusto.com/partners/accountants.

Frequently Asked Questions

- What is Gusto Pro?

Gusto Pro is Gusto's platform for accounting firms to manage payroll, benefits, and advisory services for their clients from a single dashboard.

- What is the Gusto Partner Program?

The Gusto Partner Program is a free, tiered program that helps accounting firms grow their practice while unlocking rewards along the way. Partners can access revenue share, free firm payroll, marketing resources and a dedicated advisor.

- What updates is Gusto announcing to Gusto Pro?

As of Oct. 7, 2026, Gusto is introducing a redesigned version of Gusto Pro, its most significant update since 2021. Gusto Pro now includes AI-assisted workflows that automate core payroll tasks end-to-end, like extracting hours from emails, surfacing changes since last payroll, and delivering critical reports. It also features an AI assistant built for accountants called Pro Gus.

- What's new in the Gusto Partner Program?

As of November 2026, Gusto is updating the Partner Program with Marketing Development and Partner Development funds, a Partner Marketing Hub, and AI agents built to help firms win new clients and grow their advisory services.

- When will the newly redesigned Gusto Pro and expanded Partner Program become generally available?

The redesigned Gusto Pro and expanded Partner Program are currently available to eligible Gusto partners, with general availability coming later this year.

- What are Marketing Development Funds and Partner Development Funds?

Gusto accountant partners can use the new Marketing Development Funds to drive client acquisition through marketing activities, including email campaigns, webinars, events, and paid social promotion. With the support of Firm Business Consultants, accountant partners can use the new Partner Development funds to launch and improve AI adoption and implementation, pricing and strategy for client advisory services, and operational efficiencies.

- What is the multi-client MCP?

Gusto's multi-client Model Context Protocol (MCP) brings Gusto's business context directly into the AI tools accountants already work in, across every client they manage.

Until now, working with AI across a client book has meant connecting to one client at a time and disconnecting and reconnecting to switch. With the multi-client MCP, accountants connect Gusto once, choose which clients to include, and every Gusto tool works across that whole book from a single conversation.

Accountants can ask questions across their book of business, prep payroll changes like hours, earnings, time off, and payment methods, and generate the reports they run every cycle. Every change still comes back to the accountant to review and approve before anything is updated in Gusto, and only the clients they've chosen are ever connected.

- How many accounting firms use Gusto Pro?

More than 23,000 accounting firms currently use Gusto Pro to support small businesses.

About Gusto

Gusto is the leading partner for small businesses, helping them with a wide variety of critical tasks, including payroll, health benefits, tax credits, compliance, 401(k), HR, and much more. Gusto serves over 500,000 small businesses and more than 23,000 accounting firms across the US, and is on a multi-decade journey to grow the small business economy with technology and heart.

Media Contact:

Candice So

[email protected]

SOURCE Gusto, Inc.

Share this article

SAN LEANDRO, Calif., Oct. 7, 2026 /PRNewswire/ -- Fisica, Inc. ("Fisica"), a leading provider of aerospace and defense communications solutions, today announced it has been awarded a contract in support of the U.S. Space Force's Deep Space Advanced Radar Capability (DARC) program.

The award supports the development of a global network of advanced ground-based sensors designed to enhance space domain awareness. Just one year after a trilateral agreement launched the program's first phase, construction is complete at the first site in Australia, and the program is now advancing to its second site in the United Kingdom.

Awarded through a competitive bid process, Fisica secured the contract based on its successful performance supporting the first DARC site in Australia. The company's proven execution helped reduce implementation risk and positioned it as a trusted partner for the program's next phase.

The work performed by Fisica will include the design, assembly, testing, and installation of advanced radar antenna systems, and further highlights the company's expertise in delivering complex antenna systems for mission-critical environments.

"This award validates our team's ability to execute highly complex programs at scale," said Mark Rayner, President of Fisica. "We are proud to support capabilities that strengthen global security, enhance space domain awareness, and help address evolving mission requirements for the U.S. and its allies."

This award further reinforces Fisica's role as a trusted provider of advanced communications, radar, and sensing infrastructure supporting U.S. and allied operations worldwide.

For additional information about Fisica, Inc., visit www.fisica.com or contact [email protected].

SOURCE Fisica, Inc.

Share this article

Atlantic Canadian companies to advance sovereign launch safety capability from Nova Scotia's growing space and defence ecosystem

HALIFAX, NS, Oct. 7, 2026 /PRNewswire/ -- Galaxia and Maritime Launch Services Inc. (CBOE: MAXQ) (OTCQB: MAXQF) (MLS) today announced that Galaxia will develop and supply an Autonomous Flight Safety System (AFSS) for Maritime Launch, supporting launch operations from Spaceport Nova Scotia and advancing Canada's sovereign space-launch capability.

The AFSS will be designed to process launch vehicle sensor data onboard and determine whether termination criteria have been met, reducing reliance on traditional ground-based range safety processes and enabling a more automated, resilient, and scalable approach to launch safety. Drawing on Galaxia's expertise in space-qualified computing, real-time data processing, and high-reliability spacecraft systems, the AFSS will be developed as a dedicated system for demanding and challenging launch environments. It will incorporate redundant radiation-hardened controllers, deterministic real-time signal processing, multi-sensor data fusion for vehicle health monitoring, and a space-grade independent power system to support reliable operation under mission-critical conditions.

Both companies are headquartered in Atlantic Canada and are contributing to Nova Scotia's position as Canada's defence capital. The partnership brings together Maritime Launch's launch infrastructure and operations expertise with Galaxia's flight computing, and mission-critical technology development capabilities, reinforcing the region's growing role in space, defence, and advanced manufacturing.

"This partnership demonstrates how Atlantic Canadian companies are building the technologies needed for Canada to launch, operate, and protect critical space assets from Canadian soil," said Lucas Rowlands, VP, Mission Operations at Galaxia. "By developing an autonomous flight termination capability here in Nova Scotia, Galaxia is helping deliver the resilient, sovereign systems Canada needs for the next era of space access."

The development program is being funded by Maritime Launch Services with support through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). The investment supports the development of Canadian technology and domestic capability for safe and reliable launch operations.

"Maritime Launch is building the launch capability Canada needs to serve commercial, civil, and defence customers," said Melissa Quinn, VP, Spaceport Operations at Maritime Launch Services. "Working with Galaxia allows us to draw on world-class engineering talent from Atlantic Canada while strengthening the domestic supply chain that will support safe, reliable, and sovereign launch operations."

Atlantic Canada's space sector is emerging rapidly, with launch infrastructure, satellite manufacturing, mission operations, and enabling technologies developing across the region. Through this collaboration, Galaxia and MLS are helping position Nova Scotia and Atlantic Canada as leaders in the next generation of Canadian space capability, creating high-skilled opportunities and supporting national security, economic resilience, and technological independence.

About Galaxia

Galaxia is a Canadian space technology company developing advanced satellite platforms and mission infrastructure for commercial, civil, and defence customers. Through its MissionOne program and next-generation spacecraft platforms, Galaxia is helping enable responsive and sovereign space capabilities for Canada and its allies.

About Maritime Launch Services

Maritime Launch Services Inc. (CBOE: MAXQ, OTCQB: MAXQF) is a Canadian-owned commercial space company based in Nova Scotia. Maritime Launch is developing Spaceport Nova Scotia, a dual-use spaceport designed to support both civil and defence-related space missions. Spaceport Nova Scotia will provide satellite launch services to the Government of Canada and domestic and international clients across the global commercial space market, supporting a wide range of orbital inclinations from a single location.

Spaceport Nova Scotia is Canada's first orbital launch complex, enabling small and medium launch vehicles to place satellites into low Earth orbit.

https://www.linkedin.com/company/maritimelaunch

SOURCE Maritime Launch Services Inc.

Share this article

The brand's 2026 Winter collection brings varsity influence, bold seasonal color and cold-weather performance to the course beginning October 7

SCOTTSDALE, Ariz., Oct. 7, 2026 /PRNewswire/ -- Winter doesn't mean slowing down, and it definitely doesn't mean blending in. Bad Birdie, the modern golf apparel brand redefining style and expression on and off the course, today unveiled its Winter 2026 Collection, kicking off a season of new drops with Class of Bad, a fresh mix of rich seasonal color, bold prints and nostalgic athletic influences designed to bring new energy to golf's coldest months.

Class of Bad builds on the collegiate energy introduced with Fall's Tailgate Edit, carrying the school spirit into winter through varsity-inspired graphics and athletic styling that feels just as at home at the clubhouse as it does fireside.

"With Winter, we wanted to build on the momentum of Fall without simply repeating it," said Melissa Agnew, Head of Product at Bad Birdie. "We pulled inspiration from collegiate style, pairing rich seasonal color and new prints with varsity graphics and nostalgic athletic influences, then brought those elements together in a way that still felt unmistakably Bad Birdie. There's a richness to the collection that feels right for winter, but it still has that unexpected energy and sense of fun we want every Bad Birdie collection to deliver."

WELCOME TO THE 'CLASS OF BAD'

At the center of the collection is a winter palette built to break from the season's usual neutrals. Bright teal delivers an energetic hit of color; bold red brings intensity; and dark navy keeps the collection grounded, clean and easy to wear.

Layered with new prints, graphics and silhouettes, the result feels rich without feeling heavy, nostalgic without feeling retro and seasonal without playing it safe.

Headlining Class of Bad is the new Collegiate Crewneck for men and women, an elevated take on the classic varsity staple. Made in Peru from premium 100% cotton French terry, the classic-fit crewneck features a double-layer rib collar and rib cuffs and is designed to layer easily with pants, skorts or shorts for a look that moves seamlessly from the course to wherever the day goes next.

For men, the collection expands Bad Birdie's performance polo lineup with new prints including The Blooming Back Nine and Salt Shaker, while the Ridge Polo brings a clean athletic silhouette together with custom ribbed details, engineered stretch, breathability and sweat-wicking performance.

New seasonal colors also arrive in the Velocity Hoodie, Bad Birdie's lightweight performance layer that reimagines the brand's fan-favorite Quarterzip fabric in a streamlined hooded silhouette. With 4-way stretch, UPF 50 protection, anti-odor technology and temperature regulation, it's built to provide lightweight protection without sacrificing mobility or comfort.

On the women's side, The Blooming Back Nine adds a new print to Bad Birdie's performance polo assortment, while the At Ease Quarterzip and Double Down Skort arrive in a vibrant red for easy head-to-toe outfitting that brings a jolt of color to cooler-weather rounds.

PLAY THROUGH ANYTHING.

The winter season continues October 14 with the latest drop from Bad Elements, Bad Birdie's limited-release performance outerwear collection built for golfers who aren't letting a less-than-perfect forecast call the round.

Designed for wind, rain and changing conditions, Bad Elements takes inspiration from the technical construction of extreme-sports outerwear and reengineers it specifically for golf, pairing serious weather protection with the mobility and personality Bad Birdie brings to the course.

Anchoring the drop are the Atmos Rain Anorak jacket and pant, a fully waterproof system designed to keep golfers moving when the forecast refuses to cooperate. The technical construction combines unrestricted mobility with strategically placed venting, adjustable cord-lock systems and a secure hood strap engineered to keep the hood in place on windy days.

The limited-release Bad Elements collection drops annually and has consistently sold out, reinforcing a simple Bad Birdie philosophy: bad weather doesn't have to mean bad golf… or boring outerwear.

THE MOCK IS BACK

On October 21, another cold-weather favorite returns as Bad Birdie restocks its sold-out Mock Neck.

Back by popular demand after selling out quickly last season, the Mock Neck gives golfers who missed it the first time another shot, and those who didn't, a reason to add another to the rotation.

The silhouette taps into the broader resurgence of mock necks as a modern alternative to the traditional golf polo, bringing a more contemporary, fashion-forward edge to a style that has increasingly appeared on Tour.

Across the season, Bad Birdie's Winter collection is built to keep going long after the round ends, pairing performance-first function with off-course versatility and style. From layering up for an early tee time to heading straight to the clubhouse - and wherever things go from there - winter isn't an excuse to slow down. It's just another reason to layer up.

The Bad Birdie 2026 Winter collection will be available beginning October 7 at BadBirdieGolf.com, Bad Birdie retail locations, and select retailers including Dicks Sporting Goods, Nordstrom, SCHEELS, and Golf Galaxy. Products range from $72–$120 USD.

About Bad Birdie

Bad Birdie is a modern golf apparel brand redefining the game through bold design, performance-driven benefits, and a more expressive approach to golf culture. Founded to challenge the sport's traditional style norms, Bad Birdie creates technical, course-ready apparel that blends function and personality built for how today's golfers play, socialize, and live. Through innovative products, community-driven events, and cultural partnerships, Bad Birdie is helping shape a more welcoming, energetic future for golf both on and off the course. Available online at BadBirdieGolf.com and at select retail locations.

SOURCE Bad Birdie Golf

Share this article

PITTSBURGH, Oct. 7, 2026 /PRNewswire/ -- Stock Preachers Market Commentary - Major averages split this week as the Nasdaq Composite and S&P 500 held onto gains while the Dow Jones Industrial Average and Russell 2000 turned lower. The Nasdaq rose 1.05% for the week to 27,475.93, and the S&P 500 added 0.92% to 7,793.85, even as both indices fell on the latest session. The Dow slipped 0.06% for the week to 51,145.98, and the Russell 2000 dropped 1.42% to 2,792.80, underscoring a market where large-cap tech and biotech names are carrying the tape while smaller companies lag. Active Companies from around the markets with current developments this week include: RTX (NYSE: RTX), Eli Lilly and Company (NYSE: LLY), SAP SE (NYSE: SAP), International Business Machines Corporation (NYSE: IBM), and Canadian National Railway Company (TSX: CNR) (NYSE: CNI).

The Nasdaq Composite closed at 27,475.93, down 0.45% on the day but still up 1.05% for the week, with an RSI14 of 64.5 signaling a market near overbought territory. The index traded as high as 27,722.75 this week, matching its 52-week high, while support sits at 27,288.79 and 27,167.06. The S&P 500 closed at 7,793.85, down 0.32% on the day, with RSI14 at 59.4 and resistance at its 52-week high of 7,844.52.

The Dow Jones Industrial Average fell 0.73% on the day to 51,145.98, pushing its weekly change to negative 0.06%, with an RSI14 of 40.4 reflecting the index's relative weakness. The Russell 2000 posted the week's sharpest decline, down 1.32% on the day and 1.42% for the week to 2,792.80, with an RSI14 of 34.5 as small caps underperform large caps.

Volatility ticked higher with the VIX at 15.33, up 0.32 on the day though down 0.19 for the week, while the Nasdaq-100 volatility gauge (VXN) rose to 21.45. In commodities, gold fell 1.25% on the day to $4,134.90 per ounce and silver dropped 1.51% to $60.24, while WTI crude slipped to $88.89 a barrel. Natural gas jumped 3.82% on the day, and the 10-year Treasury yield rose to 5.32%.

The full report includes a detailed levels ladder for each index, a broader look at sector sentiment, and a preview of what to watch in the week ahead.

CONTINUED... Read this and more news from around this sector and may more at: Stock Preachers Market Commentary

In other industry developments and happenings in the market this week include:

RTX (NYSE: RTX) Raytheon, an RTX business, has secured a five-year contract with two additional option years, valued up to $24.4 billion, for Standard Missile-6 (SM-6) interceptors, boosting availability of the munition for offensive strikes and missile defense missions for the U.S. Navy.

"SM-6's multi-mission capability is vital to our customer, and Raytheon is intensely focused on meeting the demand," said Phil Jasper, Raytheon President. "By continuously investing in our operations and facilities, we are removing constraints and boosting capacity to ensure we deliver this critical capability our sailors depend on."

SM-6 is described as the only combat-proven weapon able to perform anti-air warfare, anti-surface warfare and ballistic missile defense, and has been fired from various U.S. Navy ship-based platforms and land-based launchers.

Eli Lilly and Company (NYSE: LLY) The U.S. FDA has approved an additional indication for Jaypirca (pirtobrutinib), a non-covalent BTK inhibitor, for adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a known 17p deletion, allowing its use as a first-line treatment for appropriate patients.

The approval is based on the BRUIN CLL-313 trial, where at a median follow-up of 28 months, progression-free survival was significantly improved with pirtobrutinib compared to bendamustine plus rituximab (HR=0.20; p0.0001), with median PFS not yet reached for pirtobrutinib versus 33.5 months for the comparator arm. Overall response rate was 94% for pirtobrutinib versus 81% for the comparator.

"This milestone underscores Jaypirca's versatility in the CLL continuum of care, from the first-line setting for appropriate patients to its valuable role in the relapsed or refractory post-covalent BTK inhibitor setting," said Jacob Van Naarden, executive vice president and president of Lilly Oncology.

SAP SE (NYSE: SAP) SAP SE and TechWolf have entered into an agreement for SAP to acquire TechWolf, provider of an AI work intelligence platform that gives enterprises a continuously updated view of the work their people do and the skills they have. The deal is expected to close in the fourth quarter of 2026, subject to regulatory approval, with terms not disclosed.

"TechWolf's proprietary context graph for skills and work provides an excellent grounding layer for agent queries regarding work and skills planning and talent management," said Manoj Swaminathan, president and chief product officer for SAP Autonomous Suite and member of the Extended Board of SAP SE.

"We have spent eight years building the evidence layer to answer those questions," said Andreas De Neve, CEO and co-founder of TechWolf, who added the company plans to "build a world-class AI company" following the acquisition. TechWolf is expected to remain an independent entity under De Neve in its Ghent headquarters.

International Business Machines Corporation (NYSE: IBM) Hagens Berman is investigating potential securities law violations by IBM after CEO Arvind Krishna previewed disastrous Q2 2026 results on July 14, 2026, a disclosure that sent IBM shares down 25% in one day, erasing over $68 billion in market capitalization.

On April 22, 2026, IBM had reported Infrastructure, Hybrid Infrastructure, and IBM Z revenues up 15%, 28% and 51% respectively, with management projecting constant currency revenue growth of 5-plus percent for 2026. By July, total revenue growth had slowed to 1% and Infrastructure revenue declined 7%.

CEO Krishna said "[w]hat played out was worse than our expectations, driven by a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing," adding "numerous large deals failed to close." "Based in part on the abruptness of the bad news, we are looking into whether and when the Company may have had information raising the probability that large deals were unlikely to timely close during IBM's second quarter," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Canadian National Railway Company (TSX: CNR) (NYSE: CNI) CN announced it set a new quarterly record for grain movement, moving 7.94 million metric tonnes of grain from Western Canada in its third quarter, surpassing the previous record of 7.48 million metric tonnes set in 2020.

The company attributed the performance to robust customer demand, close collaboration across the grain supply chain and consistent execution of its operating plan, and said it remains focused on sustaining momentum through winter.

CN recently published its 2026-2027 Winter Plan outlining proactive solutions across its network to support safe and reliable service, and will report third-quarter 2026 financial and operating results before markets open on October 30, 2026.

Contact Information:

Media Contact: [email protected]

DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited ("MEL"), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Portions of this commentary were produced with the assistance of automated tools from that data and reviewed against it. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market and sector context and as summaries of each company's own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies' own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company's filings with the SEC and applicable Canadian securities regulators.

In the news release, Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, issued 06-Oct-2026 by Alora Pharmaceuticals, LLC over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month

ALPHARETTA, Ga., Oct. 6, 2026 /PRNewswire/ -- October marks ADHD Awareness Month, shining a light on the need for timely diagnosis and personalized treatment. Vertical Pharmaceuticals is dedicated to supporting the ADHD community and the importance of precision dosing.

Approximately 11.7% of U.S. children and adolescents in the United States have been diagnosed with ADHD, while adult diagnoses are estimated to be around 6%.1 Yet, despite this prevalence, misconceptions remain, especially for women, whose symptoms may be less visible and more easily overlooked. Common symptoms of ADHD include persistent patterns of inattention, hyperactivity, and impulsivity that can affect daily functioning.2

Clinically, ADHD presents uniquely in every individual and finding the right treatment and dose can make all the difference in achieving effective symptom control. Careful dose optimization of methylphenidate has been shown to provide significant symptom management benefits, especially in children, highlighting the need for ongoing medication management. This management is made easier by the availability of multiple tablet strengths.3

"Alora, Vertical Pharmaceuticals' parent company, is driven by a commitment to innovation and patient well-being, and we're proud to stand with the ADHD community by advancing therapies that make a meaningful difference in everyday life. RELEXXII gives providers the flexibility to titrate treatment with precision, supporting the unique needs of individuals impacted by ADHD."-Art Deas, CEO, Alora Pharmaceuticals

If you or a loved one is experiencing ADHD symptoms, we encourage you to have a conversation with your healthcare provider. Together with healthcare providers, who lead diagnosis and treatment, we support precision dosing so that patients can achieve the most effective, individualized care. At Vertical Pharmaceuticals, we are committed to helping the ADHD community thrive.

For further support, explore these trusted ADHD resources for patients and caregivers: ADDitude Magazine, American Academy of Child and Adolescent Psychiatry, American Professional Society of ADHD and Related Disorders, Children and Adults with Attention-Deficit Hyperactivity Disorder, National Institute of Mental Health, and The Attention Deficit Disorder Association.

For more information on RELEXXII® please visit relexxii.com. For Important Safety Information visit relexxii.com/isi. For full Prescribing Information, including BOXED WARNING, visit relexxii.com/pi. For U.S. residents only.

About Alora Pharmaceuticals, LLC

Headquartered in Alpharetta, GA, Alora Pharmaceuticals is a pharmaceutical company driven by a commitment to quality, reliability, and affordability. Alora Pharmaceuticals is the parent company of seven specialty pharmaceutical and pharmaceutical manufacturing companies with facilities in Texas and Georgia. The Alora family of companies includes Acella Pharmaceuticals, Avion Pharmaceuticals, Neuvosyn Laboratories, Osmotica Pharmaceuticals, Sovereign Pharmaceuticals, Trigen Laboratories, and Vertical Pharmaceuticals. With more than 550 employees, the Alora family of companies is proud to manufacture medicines in the United States, supporting domestic production, supply chain resilience, and patient access to affordable treatments.

Relexxii® is a registered trademark of Vertical Pharmaceuticals, LLC.

References: 1. https://mhstats.org/blog/how-many-people-have-adhd/ 2. https://www.cdc.gov/adhd/signs-symptoms/ 3. Childress AC, et al. Clin Pharmacol Drug Dev. 2025;0(0):1-7.

Correction: An earlier version of this release required an update to the ADDitude Magazine URL in the sixth paragraph.

SOURCE Alora Pharmaceuticals, LLC

Share this article

LONDON, Oct. 7, 2026 /PRNewswire/ -- The "Cold Plasma in Healthcare Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2032" report has been added to the Credence Research Inc. offering.

The global Cold Plasma in Healthcare Market was valued at USD 2,873 million in 2025 and is projected to reach USD 6,634 million by 2032, registering a CAGR of 12.7%. Growth is being supported by expanding clinical interest in non-thermal plasma for wound management, microbial control, dermatology, dental applications and device-related sterilization workflows. Point-of-care atmospheric systems are gaining importance because they can be deployed without high-temperature treatment, while device makers are increasingly pairing hardware with consumables, training and service support to improve treatment standardization.

Key Takeaways

- The Cold Plasma in Healthcare Market is projected to grow from USD 2,873 million in 2025 to USD 6,634 million by 2032 at a CAGR of 12.7%.

- Devices led the product segment with 68.4% share in 2025, reflecting the importance of installed treatment capability before recurring consumable and service revenue scales.

- Plasma Jet held 39.6% of the technology segment, while Atmospheric Pressure Cold Plasma accounted for 66.8% of the pressure-type segment in 2025.

- Wound Healing and Chronic Wound Management was the leading application with 28.9% share, supported by repeat-treatment workflows and strong clinical interest in microbial control.

- Hospitals represented 41.7% of end-user demand in 2025, while outpatient and specialty settings are emerging as important expansion channels.

- North America led with 38.9% share in 2025, followed by Europe at 31.2% and Asia Pacific at 21.0%.

Scope & Segmentation – Cold Plasma in Healthcare Market

The report provides a comprehensive analysis of the global Cold Plasma in Healthcare Market, covering revenue forecasts through 2032. It evaluates product models, plasma technologies, pressure formats, clinical applications, end-user settings, regional adoption and competitive development.

The study places particular emphasis on medically relevant cold-plasma platforms and clinically adjacent technologies, including suppliers active in medical devices, wound care, disinfection and other healthcare applications.

- The Cold Plasma in Healthcare Market is segmented based on product type, technology, pressure type, application, end user and region.

- By Product Type, the market includes Devices, Consumables, and Services and Software.

- By Technology, the market includes Dielectric Barrier Discharge, Plasma Jet, Radio-Frequency Cold Plasma, Microwave Cold Plasma, and Other Cold Plasma Technologies.

- By Pressure Type, the market includes Atmospheric Pressure Cold Plasma and Low-Pressure / Vacuum Cold Plasma.

- By Application, the market includes Wound Healing and Chronic Wound Management, Oncology Applications, Hemostasis and Blood Coagulation, Dentistry and Oral Care, Dermatology, Sterilization and Disinfection, Implant Surface Functionalization, and Plasma-Activated Liquids and Hydrogels.

- By End User, the market includes Hospitals, Ambulatory Surgical Centers, Wound Care Centers, Specialty Clinics, Research and Academic Institutes, and Home Care Settings.

- By Region, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cold-plasma-in-healthcare-market

Why This Report Matters

- The report provides a focused view of a healthcare technology category moving from specialist use toward broader clinical and outpatient workflows.

- It helps decision-makers distinguish between cold-plasma device formats, pressure systems and application environments rather than treating plasma as a single technology class.

- The study highlights the importance of clinical evidence, training, service coverage and workflow fit in determining adoption speed.

- For medtech companies, hospitals, wound-care providers, distributors and investors, the report supports portfolio strategy, commercialization planning and regional market assessment.

Market Overview

- Industry Landscape and Value Chain Assessment

- Supply-Side Evaluation

- Demand-Side Evaluation

- Stakeholder Mapping

- Porter's Five Forces Review

- PESTLE Environment Assessment

- Market Forecast and Future Direction

- Short-Term Forecast, 0–2 Years

- Mid-Term Forecast, 3–5 Years

- Long-Term Forecast, 5–10 Years

- Market Entry and Expansion Strategy

Market Insights

- Clinical Adoption and Workflow Analysis

- Device and Consumables Economics

- Technology and Pressure-Type Benchmarking

- Application Opportunity Assessment

- Hospital and Outpatient Procurement Review

- Regulatory and Clinical Evidence Assessment

- Training and Service Infrastructure Review

- Regional Commercialization Analysis

- Investment Return and Market Expansion Assessment

Key Attributes

Segmentation

By Product Type

- Devices

- Consumables

- Services and Software

By Technology

- Dielectric Barrier Discharge

- Plasma Jet

- Radio-Frequency Cold Plasma

- Microwave Cold Plasma

- Other Cold Plasma Technologies

By Pressure Type

- Atmospheric Pressure Cold Plasma

- Low-Pressure / Vacuum Cold Plasma

By Application

- Wound Healing and Chronic Wound Management

- Oncology Applications

- Hemostasis and Blood Coagulation

- Dentistry and Oral Care

- Dermatology

- Sterilization and Disinfection

- Implant Surface Functionalization

- Plasma-Activated Liquids and Hydrogels

By End User

- Hospitals

- Ambulatory Surgical Centers

- Wound Care Centers

- Specialty Clinics

- Research and Academic Institutes

- Home Care Settings

By Region

- North America

- Europe

- Asia Pacific

- Latin America

- Middle East & Africa

Chronic Wound Burden and Point-of-Care Adoption Support Growth

Wound management remains the clearest commercial pathway for cold plasma because chronic and difficult-to-heal wounds require repeated interventions, infection control and standardized clinical workflows. Non-thermal systems are attractive where providers want localized treatment without heat-related tissue damage, and the repeat-treatment model can support sustained device utilization once protocols are established.

Atmospheric pressure platforms are particularly relevant to bedside and outpatient settings because they avoid vacuum infrastructure and can be packaged in mobile or compact formats. This supports adoption in wound-care centers, specialty clinics and hospital departments where portability and simple setup influence treatment throughput.

Device-Led Adoption Expands into Outpatient and Specialty Care

Capital equipment currently anchors the market, but installed-base expansion creates downstream opportunities for consumables, maintenance, training and software-enabled documentation. Vendors that provide protocol support and clinician education can lower adoption friction and improve treatment reproducibility across sites.

Beyond wound care, cold plasma is being evaluated or applied in dentistry, dermatology, sterilization, implant surface treatment and other specialty workflows. The commercial opportunity differs by application maturity, so credible clinical evidence and clear regulatory positioning remain central to market development.

Market Challenges Include Clinical Evidence Requirements, Procurement Scrutiny and Service Coverage

Healthcare buyers require clear evidence of safety, reproducibility and workflow value before scaling new treatment modalities. The evidence base is stronger in selected wound-care uses than in some emerging applications, which can lead to different adoption timelines across the segmentation.

Capital equipment procurement competes with other hospital priorities, making total cost of ownership, staff training, maintenance and local service availability important purchasing considerations. Limited support infrastructure can slow expansion in newer markets even when clinical interest is present.

Regulatory status and approved indications differ across devices and geographies. Suppliers must therefore avoid overextending claims and align commercialization with jurisdiction-specific approvals, clinical protocols and practitioner training.

Key Player Analysis

- terraplasma medical GmbH

- neoplas med GmbH

- Plasmacure B.V.

- Coldplasmatech GmbH

- Adtec Healthcare / Adtec Plasma Technology

- Viromed Medical AG

- relyon plasma GmbH

Recent Industry Developments

- In February 2025, Royal Wound-X, a division of Royal Biologics, entered a strategic partnership with Coldplasmatech GmbH focused on complex and chronic wound care using Cold Atmospheric Plasma technology.

- In April 2025, Viromed Medical AG signed an exclusive distribution agreement with UMECO Group covering commercialization of the ViroCAP and PulmoPlas cold-plasma medical devices in ten Asian markets.

- In June 2025, neoplas med introduced its Argon Cold Plasma Jet kINPen MED in Oman at a launch event in Muscat attended by healthcare professionals from public and private institutions.

Report Coverage

- The research report offers an in-depth analysis based on Product Type, Technology, Pressure Type, Application, End User and Region.

- It assesses device adoption, clinical workflow fit, consumables and service economics, regional commercialization and competitive positioning.

- The report distinguishes established and emerging applications and evaluates clinical evidence, procurement, training and regulatory factors that influence adoption.

- It provides strategic guidance for medical device companies, healthcare providers, distributors and investors assessing cold-plasma commercialization opportunities.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.